Experts need integrity and benevolence above all else to gain public trust.Andrew Coop, PhD, MA, professor in the Department of Pharmaceutical Sciences and associate dean for Graduate Programs in the University of Maryland School of Pharmacy, shared those words during the third annual Faculty Convocation at the University of Maryland, Baltimore.Dr. Coop has been a faculty member at the University of Maryland School of Pharmacy since 1999, serving as chair of the Department of Pharmaceutical Sciences (PSC) from 2007 to 2015. In addition to his current role as UMSOP’s associate dean for graduate programs, he previously served as the school’s associate dean for academic affairs from 2016 to 2024 and as PSC’s vice chair of academic affairs from 2006 to 2007.Dr. Coop has received funding from the National Institutes of Health’s National Institute on Drug Abuse for his research on opioids, stimulants, and depressants, all of which were interdisciplinary projects concerned with the design and development of novel tools to allow pharmacological study of the biological systems involved in the abuse of these drugs.
More from Youtube
- 1:01:47Virtual Face to Face: Facing the Future Together: A Conversation with Presidents Jarrell and PinesOn June 26, 2025 University of Maryland, Baltimore President Bruce Jarrell and University of Maryland, College Park President Darryll Pines discussed the challenges facing higher education today and how they are working together to overcome them. In this Virtual Face to Face program a live audience was able to pose questions about university-based research, international students, student finance, and more.
- 3:50Hitting the Brakes on Dangerous Inflammation | Breakthroughs Can't WaitCould a new class of drugs rebalance the body and prevent excessive inflammation?Paul Shapiro, PhD, professor at the University of Maryland School of Pharmacy and partner Jeffrey Hasday, MD, professor at the University of Maryland School of Medicine are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases. The secret is protein kinases, enzymes that regulate how various proteins interact and alter how they function.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #InflammationResearch #DrugDiscovery #ProteinKinase, #MedicalBreakthrough #ChronicInflammation #BiomedicalResearch #PharmaceuticalScience #TranslationalMedicine #UMBresearch #EnzymeTherapy #InflammationTreatment, #FutureOfMedicine #LifeSavingResearch, #HealthInnovation
- 0:34How Modulating Protein Kinases May Help Alleviate DiseaseProtein kinases help regulate inflammation — but what happens when their activity goes unchecked?At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are exploring how adjusting kinase activity may help reduce the severity of inflammation-related diseases.Watch how this breakthrough could lead to new strategies for improving long-term health. #ProteinKinases #HealthResearch #PharmacyInnovation #InflammationScience #MedicalBreakthrough #BreakthroughsCantWaitUMB
- 0:40Balancing Inflammation: Hope for Reducing ARDS ComplicationsWhat if we could help the body manage inflammation before it becomes dangerous? At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB
- 0:57Anti-Inflammatory Drug Offers Hope | Breakthroughs Can't WaitWhat if we could reset the balance between inflammation and anti-inflammation in the body?That’s exactly what researchers Paul Shapiro, PhD (University of Maryland School of Pharmacy), and Jeffrey Hasday, MD (University of Maryland School of Medicine), are working toward.By exploring protein kinases—enzymes involved in regulating inflammation—they’re investigating ways to support long-term health and conditions related to immune overreaction, such as respiratory and muscular disorders.#BreakthroughsCantWaitUMB #InflammationResearch #ChronicPain #NIH
- 1:02UMB Graduate Reflections: Lia Mejia, MSW '25Lia Mejia, MSW '25, reflects on the advice to keep herself grounded in this conversation with University of Maryland, Baltimore Provost and VP Dr. Roger J. Ward, EdD, JD, MSL, MPA. Mejia graduated this spring from the University of Maryland School of Social Work with her master's degree.#Classof2025 #UMBgrad #SocialWork
